Print

Stephen Sherwin, M.D., Joins Verastem, Inc. (VSTM) Board of Directors  
3/6/2013 6:23:47 AM

Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of Stephen Sherwin, M.D., to the Board of Directors.
//-->